Last year | Last five years | All
2025 Original Articles
- Kasper S, Incalzi RA, Bozzali M, Morgado P, Siwek M (2025) Managing Depression in the Elderly: Real-World Clinical Considerations and Perspectives on the Use of Trazodone. International Clinical Psychopharmacology Int Clin Psychopharmacol,
| Weblink | - Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Electronic address: andrew.mcintosh@ed.ac.uk; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium including Kasper S (2025) Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies Cell,
| Weblink | - Olgiati P, Kasper S, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Zanardi R, Fugger G, Ferri R, Tripodi M, Baune B, Fabbri C, Mendlewicz J, Serretti A (2025) Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues J Affect Disord, 369: 1021-1030
| Weblink |
2024 Original Articles
- Zourek J, Strange R, Kasper S, Bartova L (2024) Die Rolle von Phytotherapie bei COVID-19 assoziierter Angst und Depression: Beispiele aus der Praxis. ZPT, 45: 148-156
| Weblink | - Kasper S, Eckert A (2024) Silexan in anxiety, depression, and related disorders: pharmacological background and clinical dataeur Eur Arch Psychiatry Clin Neurosci,
| Weblink | - Baldinger-Melich P, Spies M, Bozic I, Kasper S, Rujescu D, Frey R (2024) Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy Wiener Klinische Wochenschrift,
| Weblink | - Incalzi R, Kasper S, Morgado P (2024) Management of Depression JAMA, 332 (19): 1673
| Weblink | - Luca A, Luca M, Kasper S, Pecorino B, Zohar J, Souery D, Montgomery S, Ferentinos P, Rujescu D, Messina A, Zanardi R, Ferri R, Tripodi M, Baune B, Fanelli G, Fabbri C, Mendlewicz J, Serretti A (2024) Anhedonia is associated with a specific depression profile and poor antidepressant response Int J Neuropsychopharmacol, 27 : pyae005
| Weblink | - Dold M, Möller H, Volz H, Seifritz E, Schläfke S, Bartova L, Kasper S (2024) Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials Eur Psychiatry, 67 : e23
| Weblink | - Zifko U, Guendling K, Seet R, Kasper S (2024) Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for primary care Front. Pharmacol., 15: 1338235
| Weblink | - Bartova L, Fugger G, Dold M, Kautzky A, Bairhuber I, Kloimstein P, Fanelli G, Zanardi R, Weidenauer A, Rujescu D, Souery D, Mendlewicz J, Zohar J, Montgomery S, Fabbri C, Serretti A, Kasper S (2024) The clinical perspective on late-onset depression in European real-world treatment settings Int. J. Neuropsychopharmacol., 84: 59-68
| Weblink | - Kasper S, Volz H, Möller H, Schläfke S, Klement S, Anghelescu I, Seifritz E (2024) Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial Eur Arch Psychiatry Clin Neurosci,
| Weblink | - Oliva V, Martone A, Fanelli G, Domschke K, Minelli A, Gennarelli M, Martini P, Bortolomasi M, Maron E, Squassina A, Pisanu C, Kasper S, Zohar J, Souery D, Montgomery S, Albani D, Forloni G, Ferentinos P, Rujescu D, Mendlewicz J, De Ronchi D, Baune B, Serretti A, Fabbri C, Potier M, van Westrhenen R, Rybakowski F, Mehta D, Dierssen M, Janzing J, Liò P (2024) Polygenic scores of subcortical brain volumes as possible modulators of treatment response in depression Neuroscience Applied, 3: 103937
| Weblink | - Kadriu B, Deng Z, Kraus C, Johnston J, Fijtman A, Henter I, Kasper S, Zarate C (2024) The impact of body mass index on the clinical features of bipolar disorder: A STEP-BD study Bipolar Disorders, 26: 160-175
| Weblink |
2024 Reviews
- Lochmann van Bennekom M, IntHout J, Gijsman H, Akdede B, Yağcıoğlu A, Barnes T, Galling B, Gueorguieva R, Kasper S, Kreinin A, Nielsen J, Nielsen R, Remington G, Repo-Tiihonen E, Schmidt-Kraepelin C, Shafti S, Xiao L, Correll C, Verkes R (2024) Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data Schizophr Res, 272: 1-11
| Weblink |
